News

Cellectric Awarded €1m FFG Grant To Investigate Cell Lysis Technology and Clinically Validate its Prototype Electrodynamic Cell Manipulation System

Evercyte to highlight immortalized cell potential in OOAC technology at SelectBIO Europe 2024 Congress

IMC: Effizientes Recyclingverfahren für seltene Erden durch Biolaugung und Bioakkumulation

MedUni Vienna: New insights on polymicrobial infections in chronic lung diseases

Effizientes Recyclingverfahren für seltene Erden durch Biolaugung und Bioakkumulation

QMD Services: Erste In-vitro-Diagnostika-Zulassung in Rekordzeit

Sandoz: EU-Kommission zu Gast bei Sandoz in Kundl: Kommissar Hahn besichtigt letzte große Penicillin-Hochburg Europas

Basic research: Inhibition of epigenetic control enzymes in immune cells as a potential new starting point in cancer immunotherapy

30 Millionen Investment für Pharmastandort

Millioneninvestition in Pharmastandort Österreich

LEPTON Pharmaceuticals LTD and TAmiRNA GmbH enhance their collaboration

Austrian Life Science Day 2024 mit Schwerpunkt zum Thema Gesundheitsdaten

OGNT: World Prostate Cancer Day

Roche: „Jetzt reden wir!“ Frauen fordern Umbruch im Gesundheitssystem

University Vienna: Uptake of tire wear additives by vegetables grown for human consumption

VALANX Biotech Announces Promising Results in First In-Vivo Study of Novel Protein Conjugate Therapy

MedUni Vienna: Prostate cancer: Protein identified to reduce tumour growth

TMW: Innovationen aus Medizintechnik und Life Sciences

QUANTRO Therapeutics reaches a milestone in the collaboration with Boehringer Ingelheim to develop first-in-class cancer treatments

KLU: New Role of Tumor Suppressor STAT3β Discovered in Leukemia